Petr Hruz

University Hospital Basel

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Stephanie Christine Ganal-Vonarburg

Assistant Professor

University of Bern

SWITZERLAND

View details

Nerea Fernandez Trigo

University of Bern

SWITZERLAND

View details

Jan Niess

Prof.

University of Basel

SWITZERLAND

View details

Claudia Cavelti-Weder

Leitende Ärztin (chief of service)

University Hospital of Zurich

SWITZERLAND

View details

Daniel Konrad

Ordinarius (full professor)

University of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Petr Hruz

Research Interests

Explore related searches

Contact this professor

Articles (11)

Surface protein and functional analyses identify CD4+CD39+ TCR αβ+ and activated TCR Vδ1+ cells with distinct pro-inflammatory functions in Crohn's Disease lesions.

Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity.

IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis.

Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases

Liver Cirrhosis Affects the Pharmacokinetics of the Six Substrates of the Basel Phenotyping Cocktail Differently

Der IBD-Control-Fragebogen: Deutsche Übertragung und Validierung des standardisierten Fragebogens zur Messung des Outcomes aus Patientensicht bei chronisch entzündlichen Darmerkrankungen

Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme

Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis

Defer No Time, Delays Have Dangerous Ends (William Shakespeare)

Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation

Factors influencing the outcome of vedolizumab treatment: Real‐life data with objective outcome measurements

Collaborators (5)

Stephanie Christine Ganal-Vonarburg

Nerea Fernandez Trigo

Jan Niess

Claudia Cavelti-Weder

Daniel Konrad

Make your next move.